Sarepta Therapeutics, Inc. (SRPT)

NASDAQ: SRPT · Real-Time Price · USD

23.12

-0.14 (-0.60%)

At close: Oct 7, 2025, 4:00 PM EDT

23.29

+0.17 (0.74%)

After-hours: Oct 7, 2025, 7:02 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
EXONDYS 51 Revenue	-	-	Log In	Log In	Log In	Upgrade
AMONDYS 45 Revenue	-	-	Log In	Log In	Log In	Upgrade
VYONDYS 53 Revenue	-	-	Log In	Log In	Log In	Upgrade
Total PMO Products Revenue	970.60M	967.17M	Log In	Log In	Log In	Upgrade
ELEVIDYS Revenue	1.22B	820.79M	Log In	Log In	Log In	Upgrade
Total Products Revenue	2.19B	1.79B	Log In	Log In	Log In	Upgrade
Collaboration and Other Revenue	288.96M	114.02M	Log In	Log In	Log In	Upgrade
Revenue (Other)	-2.19B	-1.79B	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.48B	1.90B	Log In	Log In	Log In	Upgrade

Updated Aug 6, 2025. Data Source: Fiscal.ai.